Name | cytochrome P450, family 2, subfamily E, polypeptide 1 |
Symbol | CYP2E1 |
Aliases | CPE1; CYP2E; P450-J; P450C2E; microsomal monooxygenase; xenobiotic monooxygenase; flavoprotein-linked monooxygenase; cytochrome P450, subfamily IIE (ethanol-inducible); cytochrome P450, subfamily IIE (ethanol-inducible), polypeptide 1 |
Gene Product | - cytochrome P450, family 2, subfamily E, polypeptide 1
|
Category | |
UniGene |
Hs.75183
|
Reference Sequence |
|
OMIM and SNP |
|
Locus |
|
Summary | This gene encodes a member of the cytochrome P450 superfamily of enzymes. The cytochrome P450 proteins are monooxygenases which catalyze many reactions involved in drug metabolism and synthesis of cholesterol, steroids and other lipids. This protein localizes to the endoplasmic reticulum and is induced by ethanol, the diabetic state, and starvation. The enzyme metabolizes both endogenous substrates, such as ethanol, acetone, and acetal, as well as exogenous substrates including benzene, carbon tetrachloride, ethylene glycol, and nitrosamines which are premutagens found in cigarette smoke. Due to its many substrates, this enzyme may be involved in such varied processes as gluconeogenesis, hepatic cirrhosis, diabetes, and cancer. |
Gene Ontology | |
Expression | EST (224 ESTs, 35 libraries) |
Tissue | Breadth ? |
CPM ? |
bone | | | brain | | | liver | | | lung | | | muscle | | | nervous | | | ovary | | | testis | | | thymus | | | uncharacterized tissue | | | uterus | | |
|
SAGE (4353623 tags, 69 libraries) |
Tissue | Breadth ? |
CPM ? |
blood | | | brain | | | cervix | | | colon | | | eye | | | kidney | | | liver | | | lung | | | mammary gland | | | muscle | | | nervous | | | ovary | | | pancreas | | | prostate | | | skin | | | stomach | | | uncharacterized tissue | | | vascular | | |
|
|
Evidence | CpG Methylation in Abnormal Kidney Development
- Vieira I, Pasanen M, Raunio H, Cresteil T Expression of CYP2E1 in human lung and kidney during development and infull-term placenta: a differential methylation of the gene is involved inthe regulation process. Pharmacol Toxicol 1998 Nov;83(5):183-7.
Other key publications related to this gene
|